- Global Pharma News & Resources

Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market is expected to reach US$ 5.5 Billion by 2030

The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market was estimated at US$ 3.8 billion in 2021 and is predicted to reach US$ 5.5 billion by 2030, according to a new market analysis conducted by Future Market Insights (FMI).

Among the serious illnesses brought on by Staphylococcus aureus germs include sepsis, toxic shock syndrome, bacteremia, osteomyelitis, endocarditis, meningitis, and pneumonia. Antibiotics are used to treat certain disorders.

“Methicillin-Resistant Staphylococcus Aureus (MRSA)” refers to a variety of staphylococcus aureus that have become resistant to a wide array of antibiotics. One of the main forces influencing the market in the near future is this resistance, and in-depth research should be underway to develop new drugs.

Request a Sample of this Report:

According to FMI’s latest study, the rising incidences of MRSA all over the world are likely to create demand for safe and efficient drugs during the forecast period.

Key Takeaways of MRSA Treatment Market Study 

  • In terms of drug class, glycopeptides (vancomycin) and oxazolidinones (linezolid) are collectively expected to account for over 75% of revenue share in the MRSA treatment market owing to preference of both antibiotic classes as a first-line treatment against MRSA infections and used in more than 80% of MRSA cases treatment.
  • By route of administration, intravenous (IV) route of administration remains the recommended option. Drugs that can be administered through IV are likely to gain more than one-half of market share in the MRSA treatment market during the forecast period.
  • By indication, skin and soft tissue infections (SSTIs) are leading the market and expected to gain more than 40% of revenue share followed by the pneumonia over the forecast period.
  • Incidence of healthcare acquired MRSA is higher than community acquired MRSA, and FMI opines status-quo to remain unchanged during the assessment period
  • North America is the highest revenue generating market by region due to high incidence of MRSA infections
  • Asia Pacific is expected to witness high demand for MRSA testing systems due to high incidences of MRSA infection herein. For example – Journal of Family Medicine and Primary Care, in 2021, stated that occurrence of MRSA among kids aged 5 to 15 is between 16 and 52%. India alone accounts for 4-19% of these infections.

Ask An Analyst@

Government and Pharma Industry Focus on Working in Unison to Develop Advanced Treate  

As per University of Melbourne’s researchers, “Teixobactin” responds positively against MRSA. These results are likely to pave the way for development of antibacterial drugs to treat multi-drug resistant Gram-positive infections with thick cell wall. This will open wider doors for MRSA treatment market all over Australia and the other countries in Asia-Pacific. Teixobactin is already known for destroying Mycobacterium tuberculosis.

Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market By Category

By Drug Class :

By Indication :

  • Skin and Soft Tissue Infections (SSTIs)
  • Pneumonia
  • Bloodstream Infections
  • Surgical and Medical Infections
  • Others

By Route of Administration :

  • Intravenous
  • Oral
  • Topical
  • Nasal
  • Cutaneous
  • Intramuscular

By Type of MSRA :

  • Healthcare Acquired MRSA
  • Community Acquired MRSA
  • Hospital Acquired MRSA

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Ask for Customization:

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 09-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedIn| Twitter| Blogs

Editor Details

Last Updated: 09-Jun-2023